- Home
- ARDX vs EDN Comparison
ARDX vs EDN Comparison
Compare ARDX & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARDX | EDN |
|---|---|---|
| Founded | 2007 | 1992 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2014 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ARDX | EDN |
|---|---|---|
| Price | $5.49 | $28.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.14 | N/A |
| AVG Volume (30 Days) | ★ 3.5M | 89.6K |
| Earning Date | 04-30-2026 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,607,000.00 | N/A |
| Revenue This Year | $38.22 | $13.19 |
| Revenue Next Year | $33.85 | N/A |
| P/E Ratio | ★ N/A | $16.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.50 | $14.38 |
| 52 Week High | $8.40 | $38.10 |
Technical Indicators
Market Signals| Indicator | ARDX | EDN |
|---|---|---|
| Relative Strength Index (RSI) | 33.52 | 56.35 |
| Support Level | $4.81 | $26.15 |
| Resistance Level | $6.23 | $31.06 |
| Average True Range (ATR) | 0.26 | 1.68 |
| MACD | -0.05 | 0.27 |
| Stochastic Oscillator | 13.07 | 87.88 |
Price Performance
Historical ComparisonAbout ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.